Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 status. [electronic resource]
Producer: 20151109Description: 12877-90 p. digitalISSN:- 1949-2553
- AMP-Activated Protein Kinase Kinases
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cell Cycle Proteins -- genetics
- Cell Line, Tumor
- ErbB Receptors -- genetics
- Humans
- Lung Neoplasms -- drug therapy
- Metformin -- administration & dosage
- Microtubule-Associated Proteins -- genetics
- Neoplastic Stem Cells -- drug effects
- Protein Serine-Threonine Kinases -- genetics
- Proto-Oncogene Proteins -- genetics
- Proto-Oncogene Proteins p21(ras)
- Pyrans -- administration & dosage
- Serine Endopeptidases -- genetics
- Signal Transduction
- ras Proteins -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.